Get access

Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma

Authors

  • F. Wang,

    1. Department of Thoracic Surgery I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research, Beijing, China
    Search for more papers by this author
  • L.-Y. Shen,

    1. Department of Thoracic Surgery I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research, Beijing, China
    Search for more papers by this author
  • S.-H. Ma,

    1. Department of Thoracic Surgery I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research, Beijing, China
    Search for more papers by this author
  • N. Li,

    1. Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research, Beijing, China
    Search for more papers by this author
  • Z. Yang,

    1. Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research, Beijing, China
    Search for more papers by this author
  • K.-N. Chen

    Corresponding author
    1. Department of Thoracic Surgery I, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research, Beijing, China
    • Address correspondence to: Professor Ke-Neng Chen, MD, PhD, Department of Thoracic Surgery, Peking University Cancer Hospital and Institute, Beijing 100142, China. Email: chenkeneng@yahoo.com.cn

    Search for more papers by this author

  • F, Wang and L-Y, Shen contributed equally to this work.
  • Conflicts of interest: None declared.
  • Authors' Contributions

    Conception and design: Ke-Neng Chen.

  • Major executer of study: Ke-Neng Chen, Fei Wang.
  • Provision of Patients: Ke-Neng Chen, Fei Wang, Shao-Hua Ma, Lu-Yan Shen, Nan Li, Zhi Yang.
  • Collection and assembly of data: Ke-Neng Chen, Fei Wang, Shao-Hua Ma, Nan Li, Zhi Yang.
  • Data analysis and interpretation: Ke-Neng Chen, Fei Wang, Shao-Hua Ma, Lu-Yan Shen.
  • Manuscript writing: Ke-Neng Chen, Lu-Yan Shen.
  • Final approval of manuscript: Ke-Neng Chen, Fei Wang, Shao-Hua Ma, Lu-Yan Shen, Nan Li, Zhi Yang.

Summary

To explore the value of positron emission tomography-computed tomography (PET-CT) scan in esophageal squamous cell carcinoma (ESCC), we retrospectively summarize the results of PET-CT scan from 118 patients, with ESCC who underwent PET-CT scan in the different courses during treatment. Then, the results of PET-CT scan plus other conventional methods were analyzed to identify the value of PET-CT scan in diagnosis, staging, response evaluation, monitoring recurrence, and metastasis following treatment. It is suggested that PET-CT scan possess high value in diagnosis and gives more favorable indication in N and M staging. PET-CT scan should be translated into routine surveillance for postoperation follow up and is one of more helpful evaluators of response to chemoradiotherapy or chemotherapy.

Ancillary